Key facts
- Notable investors include EIT Food, Fresh Start (Business/Productivity Software).
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Novid 20
- ·The full record, as it builds
Funding rounds
No funding rounds for Novid 20 are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Novid 20
Developer of natural bioactive ingredients designed for functional food and oral wellness applications. The company's platform utilizes a proprietary cinnamon-derived polyphenol extract to reduce viral load across a broad spectrum of enveloped viruses, including HSV and avian flu, and is formulated into sugar-free lozenges and topical gels, enabling health-conscious consumers and animal health markets to access non-GMO, organism-friendly alternatives that support immune defense.
- Sector
- Business Products and Services (B2B)
- HQ
- Ma'ale Adumim, Israel
- Founded
- 2020
- Employees
- 3
- Website
- novid-20.com/
- Ownership
- Privately Held (backing)
Novid 20 doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Novid 20 shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Novid 20 in its N-PORT filings yet. We sweep new filings monthly.